Lack of SIRP ‐alpha reduces lung cancer growth in mice by promoting anti‐tumour ability of macrophages and neutrophils
Author:
Affiliation:
1. Department of Pulmonary Medicine, Zhongshan Hospital Fudan University Shanghai China
2. Department of Thoracic Surgery, Huadong Hospital Fudan University Shanghai China
3. Shanghai Key Laboratory of Lung Inflammation and Injury Shanghai China
Funder
National Natural Science Foundation of China
Natural Science Foundation of Shanghai
Science and Technology Commission of Shanghai Municipality
Publisher
Wiley
Subject
Cell Biology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13361
Reference45 articles.
1. Cancer Statistics, 2021
2. Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer
3. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
4. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment
5. Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment;Frontiers in Immunology;2024-07-31
2. Microglia Promote Inhibitory Synapse Phagocytosis in the Spinal Cord Dorsal Horn and Modulate Pain-Like Behaviors in a Murine Cancer-Induced Bone Pain Model;Anesthesia & Analgesia;2024-01-19
3. Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47;Nature Cancer;2024-01-10
4. SIRP-alpha-IL-6 axis induces immunosuppressive macrophages in non-small-cell lung cancer;Biochemical and Biophysical Research Communications;2023-11
5. Cisplatin‐induced oxPAPC release enhances MDSCs infiltration into LL2 tumour tissues through MCP‐1/CCL2 and LTB4/LTB4R pathways;Cell Proliferation;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3